+ Watch SNY
on My Watchlist
A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.
Undervalued plus ~3% to 4% dividend.The value has been tricky to estimate as the company has so much equity. If I only consider the present value of the ability to generate FCF I get a value of $49 (Std. Dev = $6)
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions